T. Sørensen

发表

Assessment of central blook volume in cirrhosis by radionusclide angiography: What does it really mean?

A. Gerbes, J. Henriksen, F. Bendtsen, 1994, Hepatology.

Critical Appraisal of Epidemiological Studies and Clinical Trials. 2nd edn. J. Mark Elwood, Oxford University Press, Oxford, 1998. No of pages: 448. Price: £29.50. ISBN 0‐19‐262745‐7

T. Sørensen, 2001 .

Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

A. Andersen, J. Holst, H. Klein, 1979, Scandinavian journal of gastroenterology.

Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

F. Stadil, J. Holst, T. Sørensen, 1983, Digestion.

Dissociation of changes in plasma cholesterol and hepatic cholesterol synthesis, assessed by precursors in bile, after jejunoileal bypass with 3:1 and 1:3 jejunoileal ratio.

T. Miettinen, T. Sørensen, B. Andersen, 1989, Scandinavian journal of gastroenterology.

Fasting and meal-stimulated plasma levels of neurotensin in obese patients after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

F. Stadil, T. Sørensen, B. Andersen, 1987, Scandinavian journal of gastroenterology.

Is there an inherited general susceptibility to cancer?

T. Sørensen, 1995, The New England journal of medicine.

Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis

J. Henriksen, F. Bendtsen, T. Sørensen, 1991, Hepatology.

Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.

J. Henriksen, F. Bendtsen, U. Becker, 1987, Journal of hepatology.

Comparison of the diagnosis of oesophageal varices by oesophagoscopy and transhepatic portography.

T. Sørensen, J. Aagaard, L. Jensen, 2008, Liver.

Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics.

N. Christensen, J. Henriksen, F. Bendtsen, 1990, Journal of hepatology.

There is room for diminished central and arterial blood volume in cirrhosis

J. Henriksen, F. Bendtsen, H. Ring‐Larsen, 1991, Hepatology.

Effects of treatments in clinical trials: Surgery

T. Sørensen, 1993, Journal of surgical oncology. Supplement.

Faecal steroids after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

T. Miettinen, E. Hylander, T. Sørensen, 1985, Scandinavian journal of gastroenterology.

Serum levels and clearance of bile acids are unaffected by jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

A. Nyboe Andersen, T. Sørensen, B. Andersen, 1981, Scandinavian journal of gastroenterology.

Jejunum and bile acid synthesis. Comparison of effects of jejunoileal bypass with 3:1 and 1:3 jejunoileal ratio.

T. Sørensen, 1982, Scandinavian journal of gastroenterology.

Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices.

J. Henriksen, F. Bendtsen, T. Sørensen, 1991, Scandinavian journal of gastroenterology.

Propranolol and haemodynamic response in cirrhosis.

J. Henriksen, F. Bendtsen, T. Sørensen, 1991, Journal of hepatology.

Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: Analysis of hospitalization registry data

T. Almdal, Thomas P. Almdal, Thorkild I. A. Sørensen, 1991, Hepatology.

Bile acid malabsorption after jejunoileal bypass is less compensated for with a 1:3 than with a 3:1 jejunoileal ratio.

T. Sørensen, B. Andersen, A. Bruusgaard, 1982, Scandinavian journal of gastroenterology.

Cholesterol saturation of bile after jejunoileal bypass increases more with a 1:3 than with a 3:1 jejunoileal ratio.

A. Andersen, T. Sørensen, L. R. Pedersen, 1981, Scandinavian journal of gastroenterology.

Results of hepatic lobectomy for primary epithelial cancer in 31 adults.

A. Bergan, T. Sørensen, H. Baden, 1979, American journal of surgery.

Whipple's operation in 37 patients with periampullary carcinoma.

T. Sørensen, H. Baden, 1979, American journal of surgery.

Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices.

T. Sørensen, F. Burcharth, M. Pedersen, 1984, Gut.

Reduced central blood volume in cirrhosis.

J. Henriksen, F. Bendtsen, H. Ring‐Larsen, 1989, Gastroenterology.

Comparison of splenoportography and transhepatic portography in the diagnosis of portal vein thrombosis.

T. Sørensen, J. Aagaard, L. Jensen, 1986, Journal of hepatology.

The free portal pressure in awake patients with and without cirrhosis of the liver.

T. Sørensen, J. Aagaard, L. Jensen, 2008, Liver.

Portographic findings and coagulopathy in cirrhosis.

B. Jacobsen, J. Hahn‐Pedersen, T. Sørensen, 2008, Liver.

Recanalized umbilical vein in portal hypertension.

T. Sørensen, J. Aagaard, L. Jensen, 1982, AJR. American journal of roentgenology.

Prospective study of malabsorption induced risk of gall stone formation in relation to fall in plasma cholesterol.

E. Hylander, H. Klein, T. Sørensen, 1988, Gut.

Risk of gallstone formation after jejunoileal bypass increases more with a 1:3 than with a 3:1 jejunoileal ratio.

H. Klein, T. Sørensen, K. Laursen, 1980, Scandinavian journal of gastroenterology.

Total plasma cholesterol in obesity after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. A randomized trial.

T. Sørensen, B. Andersen, L. Kam-Hansen, 1979, Scandinavian journal of gastroenterology.

Plasma cholesterol fractions after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

T. Sørensen, F. Damgaard-Pedersen, B. Andersen, 1982, Scandinavian journal of gastroenterology.

Lithogenic index of bile after jejunoileal bypass operation for obesity.

T. Sørensen, A. Bruusgaard, 1977, Scandinavian journal of gastroenterology.

The Journal Impact Factor as a Predictor of Trial Quality and Outcomes: Cohort Study of Hepatobiliary Randomized Clinical Trials

Christian Gluud, Peter C Gøtzsche, P. Gøtzsche, 2005, The American Journal of Gastroenterology.

Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices: multistage competing-risks model compared to conventional methods. The Copenhagen Esophageal Varices Sclerotherapy Project.

T. Sørensen, B. Thomsen, 1998, Journal of hepatology.

Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Copenhagen Esophageal Varices Sclerotherapy Project.

S. Møller, T. Sørensen, B. Thomsen, 1994, Journal of hepatology.

Who benefits from endoscopic sclerotherapy of bleeding oesophageal varices? Proposal for differential indications. The Copenhagen Esophageal Varices Sclerotherapy Project.

N. Tygstrup, S. Møller, T. Sørensen, 1992, Journal of Hepatology.

Session 9 ‒ Methodology of Future Trials: Prognostic Stratification, Health-Related Quality of Life and Health Economics

P. Kamath, G. D’Amico, O. Riggio, 2008 .

Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding

L. Skovgaard, F. Bendtsen, P. Matzen, 1990, Hepatology.

Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity, β‐adrenergic blockade and atrial natriuretic factor

N. Christensen, A. Gerbes, J. Henriksen, 1992, Hepatology.

Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: Analysis of hospitalization registry data

T. Almdal, T. Sørensen, 1991, Hepatology.

Failure of combined efforts: propranolol and sclerotherapy do not add up to the prevention of variceal bleeding.

T. Sørensen, 1993, Journal of Hepatology.